Metocard Zk (Metoprolol Tartrate)

Metoprolol tartrate works by selectively blocking β1‑adrenergic receptors in the heart. This inhibition reduces the influence of adrenaline and noradrenaline, leading to slower heart rate, decreased contractile strength, and lower renin release, which together lower blood pressure and myocardial oxygen demand.

The dose of Metocard Zk is individualized by the prescribing clinician based on the patient’s condition, response, and tolerability. Dosage may be started low and titrated upward, but exact amounts and schedules must be determined by a qualified healthcare professional.

Safety data for metoprolol tartrate in pregnancy and lactation are limited. It is generally classified as a drug to be used only if the potential benefit justifies the potential risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss risks with their physician.

To request Metocard Zk, visit the product page on gnhindia.com, enter the desired quantity, and submit the enquiry form. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Metocard Zk (metoprolol tartrate) is a cardio‑selective β1‑blocker, offering a favorable profile for patients with hypertension, angina, or heart failure. Compared with non‑selective agents, it tends to cause fewer respiratory side effects, but individual response varies, and choice of beta blocker depends on comorbidities, dosing convenience, and physician preference.

Metocard Zk should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original packaging, protect them from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Metocard Zk is taken orally, usually with a glass of water. It can be administered with or without food, but consistency with meals may help reduce gastrointestinal upset. Patients should follow the prescribing clinician’s instructions regarding timing and whether the dose is taken once or multiple times per day.

Serious adverse events include marked bradycardia (very slow heart rate) and severe bronchospasm, especially in individuals with underlying airway disease. Patients should seek immediate medical attention if they experience fainting, extreme fatigue, difficulty breathing, or any signs of heart block.

Metocard Zk is contraindicated in patients with known hypersensitivity to metoprolol or other beta blockers, those with severe bradycardia, second‑ or third‑degree heart block without a pacemaker, cardiogenic shock, and uncontrolled heart failure. Caution is also advised for individuals with severe asthma or chronic obstructive pulmonary disease.